IFMAD 2021 – 22 – 24 July 2021 100% virtual format
After this pandemic year, this IFMAD edition will provide an even more comprehensive scientific and educational programme. Difficult clinical challenges are dissected, discussed and reformulated with high ranking experts to achieve the best evidence based path to treatment in depression, anxiety and bipolar disorder. To avoid bias, our educational program is completely independent from pharmaceutical support. We will work hard to provide everyone a virtual experience, that will enable you to connect and access the latest research through a new format.
Topics discussed: Treatment Resistant Depression, Augmentation strategies in MDD, Prevention of suicide, Inflammation and Cognition in Mood and Anxiety Disorders, ADHD in adults, COVID-19 lockdown effects on mental Health, Preventing Illness Progression in Bipolar Disorder, Personalised psychiatry: are we there yet?
Journal articles and more to your inbox
Get the latest clinical insights from touchNEUROLOGYSign me up!